織田 成人 おだ しげと 先生

来歴等

略歴

1978年 千葉大学医学部卒業 第二外科入局
1986年 アメリカ Duke 大学麻酔科 留学
1988年 千葉大学医学部附属病院救急部・集中治療部 助手
2006年 千葉大学大学院医学研究院救急集中治療医学 教授
2019年 千葉市立海浜病院　救急科統括部長

1978年 千葉大学医学部 卒業
1978年 千葉大学医学部第二外科 入局
1986年 アメリカDuke大学麻酔科 留学
1988年 千葉大学医学部附属病院救急部・集中治療部 助手
2006年 千葉大学大学院医学研究院救急集中治療医学 教授
2019年 千葉市立海浜病院 救急科統括部長

論文

• Eicosanoids and the hemodynamic course of live Escherichia Coli-induced sepsis in baboons. Circ Shock. 29,229-244, 1989.

  Camporesi EM, Oda S, Fracica PJ, Griebel JA, Shook JE, Piantadosi CA, Watkins WD.

• Cellular injury score for multiple organ failure severity scoring system J Trauma. 45:304-311, 1998.

  Oda S, Hirasawa H, Sugai T, Shiga H, Matsuda K, Ueno H.

• Comparison of sepsis-related organ failure assessment (SOFA) score and CIS　(cellular injury score) for scoring of severity for patients with multiple organ dysfunction syndrome (MODS). Intensive Care Med 26:1786-1793, 2000.

  Oda S, Hirasawa H, Sugai T, Shiga H, Nakanishi K, Kitamura N, Sadahiro T, Hirano T.

• Continuous hemofiltration/ hemodiafiltration in critical care. Ther Apher 6:193-198, 2002.

  Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M.

• Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro study. Blood Purif 22:530-536, 2004.

  Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M, Ikeda H, Sakai M.

• Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/ sepsis. Cytokine 29:169-175, 2005.

  Oda S, Hirasawa H, Shiga H, Nakanishi K, Matsuda K, Nakamura M.

• Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter (PMMA-CHDF). Ther Apher Dial 9:355-361, 2005.

  Oda S, Hirasawa H, Shiga H, Matsuda K, Nakamura M, Watanabe E, Moriguchi T.

• YKL-40 identified by proteomic analysis as a biomarker of sepsis. SHOCK 32：393‐400, 2009.

  Hattori N, Oda S, Sadahiro T, Nakamura M, Abe R, Shinozaki K, Nomura F, Tomonaga T, Matsushita K, Kodera Y, Sogawa K, Satoh M, Hirasawa H.

• Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure. Transfusion and Apheresis Science 41：61‐70, 2009.

  Yokoi T, Oda S, Shiga H, Matsuda K, Sadahiro T, Nakamura M, Hirasawa H.

• The effects of body temperature control on cytokine production in a rat model of ventilator-induced lung injury. Cytokine 47：48‐55, 2009.

  Morita Y, Oda S, Sadahiro T, Nakamura M, Oshima T, Otani S, Hirasawa H.

• S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: a systematic review. Critical Care 13：R121, 2009.

  Shinozaki K, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Abe R, Tateishi Y, Hattori N, Shimada T, Hirasawa H.

• TNF-α contributes to axonal sprouting and functional recovery following traumatic brain injury. Brain Reserch 1290：102‐110, 2009.

  Oshima T, Lee S, Sato A, Oda S, Hirasawa H, Yamashita T.

• Clinical application of cytokine-related gene polymorphism analysis using a newly developed DNA chip in critically ill patients. Clinical Biochemistry 42：1387‐ 1393, 2009.

  Otani S, Oda S, Sadahiro T, Nakamura M, Watanabe E, Nakada T, Abe R, Tokuhisa T, Hirasawa H.

• Outcome prediction in sepsis combined use of genetic polymorphisms-A study in Japanese population. Cytokine 54：79‐84, 2011.

  Shimada T, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Abe R, Nakada TA, Tateishi Y, Otani S, Hirasawa H, Tokuhisa T, Uno H.

• Blood ammonia and lactate levels on hospital arrival as a predictive biomarker in patients with out-of-hospital cardiac arrest. Resuscitation 82：404‐409, 2011.

  Shinozaki K, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Tateishi Y, Nakanishi K, Kitamura N, Sato Y, Hirasawa H.

• Leucyl/cystinyl aminopeptidase gene variants in septic shock. Chest 139：1042‐1049, 2011.

  Nakada T, Russell JA, Wellman H, Boyd JH, Nakada E, Thain KR, Thair SA, Hirasawa H, Oda S, Walley KR.

• Association of angiotensin II type 1 receptor-associated protein gene polymorphism with increased mortality in septic shock. Critical Care Medicine 39：1641-1648, 2011.

  Nakada T, Russell JA, Boyd JH, McLaughlin L, Nakada E, Thair SA, Hirasawa H, Oda S, Walley KR.

• Duration of well-controlled core temperature correlates with neurological outcome in patients with post-cardiac arrest syndrome. American Journal of Emergency Medicine 30：1838‐1844, 2012.

  Shinozaki K, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Tateishi Y, Nakanishi K, Kitamura N, Hirasawa H.

• Correlation between high blood IL-6 level, hyperglycemia, and glucose control in septic patients. Critical Care 16：R58, 2012.

  Nakamura M, Oda S, Sadahiro T, Watanabe E, Abe R, Nakada TA, Morita Y, Hirasawa H.

• Kinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsis. Critical Care 17：R160, 2013.

  Takahashi W, Watanabe E, Fujimura L, Watanabe-Takano H, Yoshidome H, Swanson P, Tokuhisa T, Oda S, Hatano M.

• Serum procalcitonin level and sofa score at discharge from the intensive care unit predict post-intensive care unit mortality: a prospective study. PLoS ONE 9(12): e114007, 2014.

  Matsumura Y, Nakada T, Abe R, Oshima T, Oda S.

• Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: A preliminary report. Blood Purification 38：211‐218, 2014.

  Shiga H, Hirasawa H, Nishida O, Oda S, Nakamura M, Mashiko K, Matsuda K, Kitamura N, Kikuchi Y, Fuke N.

• The Japanese guidelines for the management of sepsis. Journal of Intensive Care 2：55, 2014.

  Oda S, Aibiki M, Ikeda T, Imaizumi H, Endo S, Ochiai R, Kotani J, Shime N, Nishida O, Noguchi T, Matsuda N, Hirasawa H, Sepsis Registry Committee of The Japanese Society of Intensive Care Medicine.

• Reduction of unexpected serious adverse events after introducing medical emergency team. Acute Medicine & Surgery 2：244‐249, 2015.

  Kawaguchi R, Nakada T, Oshima T, Abe R, Matsumura Y, Oda S.

• Interleukin-6 levels act as a diagnostic marker for Infection and a prognostic marker in patients with organ dysfunction in intensive care units. SHOCK 46：254‐260, 2016.

  Takahashi W, Nakada T, Yazaki M, Oda S.

• Pharmacokinetics of standard-and reduced-dose recombinant human soluble thrombomodulin in patients with septic disseminated intravascular coagulation during continuous hemodiafiltration. Frontiers in medicine 4：1-8, 2017.

  Watanabe E, Yamazaki S, Setoguchi D, Sadahiro T, Tateishi Y, Suzuki T, Ishii I, Oda S.

• A safe procedure for connecting a continuous renal replacement therapy device into an extracorporeal membrane oxygenation circuit.. Journal of Artificial Organs 20：125-131, 2017.

  Suga N, Matsumura Y, Abe R, Hattori N, Nakada T, Oda S.

• Proteome analysis of hemofilter adsorbates to identify novel substances of sepsis: a pilot study. Journal of artificial organs 20：132-137, 2017.

  Hashida T, Nakada T, Mamoru M, Tomita K, Kawaguchi R, Nomura F, Oda S.

• Efficient CO2 removal using extracorporeal lung and renal assist device. Journal of Artificial Organs 21:427-434, 2018.

  Takahashi N, Nakada T, Oda S.

• The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). Acute medicine & surgery 5：3-89, 2018.

  Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, Imaizumi H, Inoue S, Kakihana Y, Kotani J, Kushimoto S, Masuda Y, Matsuda N, Matsushima A, Nakada T, Nakagawa S, Nunomiya S, Sadahiro T, Shime N, Yatabe T, Hara Y, Hayashida K, Kondo Y, Sumi Y, Yasuda H, Aoyama K, Azuhata T, Doi K, Doi M, Fujimura N, Fuke R, Fukuda T, Goto K, Hasegawa R, Hashimoto S, Hatakeyama J, Hayakawa M, Hifumi T, Higashibeppu N, Hirai K, Hirose T, Ide K, Kaizuka Y, Kan'o T, Kawasaki T, Kuroda H Matsuda A, Matsumoto S, Nagae M, Onodera M, Ohnuma T, Oshima K, Saito N, Sakamoto S, Sakuraya M, Sasano M, Sato N, Sawamura A, Shimizu K, Shirai K, Takei T, Takeuchi M, Takimoto K, Taniguchi T, Tatsumi H, Tsuruta R, Yama N, Yamakawa K, Yamashita C, Yamashita K, Yoshida T, Tanaka H , Oda S.

著書

• 【共著】Oda S, Sadahiro T, Hirayama Y, Nakamura M, Watanabe E, Tateishi Y, Hirasawa H. Non-renal indications for continuous renal replacement therapy: Current status in Japan. Hiromichi Suzuki, Hiroyuki Hirasawa Eds, Acute Blood Purification (Contributions to Nephrology) , KARGER, Switzerland, pp47‐53, 2010.

• 【共著】Oda S, Matsuda K, Hirasawa H. Cytokine adsorbing membrane : PMMA. Thomas Ming Swi Chang, Yoshihiro Endo, Volodymyr G Nikolaev, Tohru Tani, Yaoting Yu, Wen-Hui Zheng Eds, Hemoperfusion, Plasmaperfusion and Other Clinical Uses of General, Biospecific, Immuno and Leucocyte Adsorbents, World Scientific Publishing　Co. Pte. Ltd., Singapore, pp433‐451, 2017.

• 【監修】医療スタッフのためのやさしく解説！日本版敗血症診療ガイドライン、学研メディカル秀潤社、東京、pp18-21，2013年

• 【共著】一般社団法人 日本救急医学会監修　救急診療指針改定第5版、へるす出版、東京、pp672‐677，2018年

• 【共著】監修 北野正剛 編集 坂井義治 田邉稔 池田徳彦監修：標準外科学、医学書院、東京、pp16-27，2019年